Evidence map›Paper›PMID 32492937›Full record

ArticleInternational journal of molecular sciences2020

The ENDpoiNTs Project: Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity.

Diana Lupu, Patrik Andersson, Carl-Gustaf Bornehag, Barbara Demeneix, Ellen Fritsche, Chris Gennings, Walter Lichtensteiger, Marcel Leist, Pim E G Leonards, Anne-Louise Ponsonby and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 11 countries.

Diana LupuEvolutionary Biology Centre, Uppsala University, 75236 Uppsala, Sweden.ORCID 0000-0002-8814-9883
Patrik AnderssonFaculty of Science and Technology, Umeå University, 90187 Umeå, Sweden.ORCID 0000-0002-2088-6756
Carl-Gustaf BornehagDepartment of Health Sciences, Karlstad University, 65188 Karlstad, Sweden.
Barbara DemeneixEvolution of Endocrine Regulations UMR 7221, Centre National de la Recherche Scientifique, 75005 Paris, France.
Ellen FritscheIUF-Leibniz Research Institute for Environmental Medicine, 40225 Düsseldorf, Germany.
Chris GenningsDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-6058-5907
Walter LichtensteigerGREEN Tox GmbH, CH-8057 Zürich, Switzerland.
Marcel LeistIn Vitro Toxicology and Biomedicine, University of Konstanz, D-78457 Konstanz, Germany.
Pim E G LeonardsDepartment Environment and Health, Vrije University, 1081HV Amsterdam, The Netherlands.ORCID 0000-0002-3052-8848
Anne-Louise PonsonbyMurdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Martin ScholzeInstitute of Environment, Health and Societies, Brunel University London, Uxbridge UB8 3PH, UK.
Giuseppe TestaDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Jesus A F TresguerresDepartment of Physiology, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Remco H S WesterinkInstitute for Risk Assessment Sciences (IRAS), Faculty of Veterinary Medicine, Utrecht University, 3584 CM Utrecht, The Netherlands.
Bernard ZalcSorbonne Université, Inserm, CNRS, ICM-GH Pitié-Salpêtrière, 75651 Paris, France.
Joëlle RüeggEvolutionary Biology Centre, Uppsala University, 75236 Uppsala, Sweden.
Centre National de la Recherche Scientifique · FRUppsala University · SEBrunel University of London · GBGREEN Tox (Switzerland) · CHIcahn School of Medicine at Mount Sinai · USKarlstad University · SELeibniz Institute of Environmental Medicine · DERoyal Children's Hospital · AUUmeå University · SEUniversidad Complutense de Madrid · ESUniversity of Konstanz · DEUniversity of Milan · ITUtrecht University · NLVrije Universiteit Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquitous exposure to endocrine-disrupting chemicals (EDCs) has caused serious concerns about the ability of these chemicals to affect neurodevelopment, among others. Since endocrine disruption (ED)-induced developmental neurotoxicity (DNT) is hardly covered by the chemical testing tools that are currently in regulatory use, the Horizon 2020 research and innovation action ENDpoiNTs has been launched to fill the scientific and methodological gaps related to the assessment of this type of chemical toxicity. The ENDpoiNTs project will generate new knowledge about ED-induced DNT and aims to develop and improve in vitro, in vivo, and in silico models pertaining to ED-linked DNT outcomes for chemical testing. This will be achieved by establishing correlative and causal links between known and novel neurodevelopmental endpoints and endocrine pathways through integration of molecular, cellular, and organismal data from in vitro and in vivo models. Based on this knowledge, the project aims to provide adverse outcome pathways (AOPs) for ED-induced DNT and to develop and integrate new testing tools with high relevance for human health into European and international regulatory frameworks.

Indexed as

AnimalsEndocrine DisruptorsEndocrine SystemEnvironmental ExposureEnvironmental MonitoringGuidelines as TopicHumansMiceNervous SystemNeuronsRatsRisk AssessmentToxicity TestsTranscriptomeEndocrine Disruptorsadverse outcome pathwayschemical testingdevelopmental neurotoxicityendocrine-disrupting chemicals

Identifiers

PMID32492937
PMCPMC7312023
OpenAlexW3032648686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.